Alameda, CA, United States of America

Csaba J Peto

USPTO Granted Patents = 26 

 

 

Average Co-Inventor Count = 7.4

ph-index = 6

Forward Citations = 163(Granted Patents)


Location History:

  • Alameda, CA (US) (2009 - 2023)
  • San Francisco, CA (US) (2020 - 2023)

Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
Loading Chart...
26 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Csaba J Peto

Introduction: Csaba J Peto, located in Alameda, CA, has made significant strides in the field of pharmaceuticals, particularly in cancer treatment. With a portfolio of 24 patents, his work exemplifies the dedication and creativity necessary to drive innovation within the pharmaceutical industry.

Latest Patents: Among his latest contributions, Peto has developed anti-cancer compounds, providing new avenues for treating diseases such as cancer. These inventions include pharmaceutical formulations with these compounds and combinations with additional therapeutic agents. Furthermore, he has disclosed MEK inhibitors, which are compounds that can help in treating proliferative diseases. These patented compounds and their pharmaceutical compositions demonstrate a commitment to advancing cancer treatment methodologies.

Career Highlights: Throughout his career, Peto has gained invaluable experience working with reputable institutions including Exelixis, Inc. and the University of California. His work at these organizations has allowed him to be at the forefront of pharmaceutical research and innovation, significantly contributing to the understanding and treatment of cancer.

Collaborations: Peto has had the opportunity to collaborate with prominent coworkers such as Tsze Tsang and Kenneth D Rice. These collaborations have fostered a productive environment for innovation, resulting in the development of groundbreaking patents that stand to benefit the medical community.

Conclusion: Csaba J Peto's contributions to the field of cancer research and treatment are truly remarkable. With his substantial number of patents and collaborative efforts, he continues to push the boundaries of innovation in the pharmaceutical industry, aimed at improving patient outcomes in cancer therapy. His work not only highlights the critical importance of research institutions and commercial entities but also showcases the impact of dedicated inventors in creating cutting-edge solutions for complex health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…